Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Arne Stenberg"'
Autor:
Ammar Al-Mashhadi, Michael Häggman, Göran Läckgren, Sam Ladjevardi, Tryggve Nevéus, Arne Stenberg, A. Erik G. Persson, Mattias Carlström
Publikováno v:
Upsala Journal of Medical Sciences, Vol 123, Iss 4, Pp 216-224 (2018)
Background: As much as 20% of all cases of hypertension are associated with kidney malfunctions. We have previously demonstrated in animals and in pediatric patients that hydronephrosis causes hypertension, which was attenuated by surgical relief of
Externí odkaz:
https://doaj.org/article/5e753e5e54704ca7be6e9d0932fdc6e5
Autor:
Göran Läckgren, Arne Stenberg
Publikováno v:
Therapeutic Advances in Urology, Vol 1 (2009)
Vesicoureteral reflux (VUR) affects around 1% of all children. It carries an increased risk of febrile urinary-tract infections (UTIs) and is associated with impaired renal function. Antibiotic prophylaxis is an established approach to managing the c
Externí odkaz:
https://doaj.org/article/a5464a2e9e9247d09ac05be645d0f1ed
Autor:
A. Erik G. Persson, Tryggve Nevéus, Nils Wåhlin, Mattias Carlström, Ammar Nadhom Farman Al-Mashhadi, Arne Stenberg, Antonio Checa, Birgitta Karanikas, Magdalena Fossum, Craig E. Wheelock
Publikováno v:
Pediatric Nephrology (Berlin, Germany)
Objective Recent clinical studies have suggested an increased risk of elevated arterial pressure in patients with hydronephrosis. Animals with experimentally induced hydronephrosis develop hypertension, which is correlated to the degree of obstructio
Autor:
Gillian Barker, Anders Stenbäck, Erik Sköldenberg, Thora Olafsdottir, Göran Läckgren, Arne Stenberg
Publikováno v:
Journal of pediatric urology. 16(3)
Summary Background Since 1993, children aged >1 year with persistent grade III–V vesicoureteral reflux (VUR) and febrile urinary tract infections (UTIs) attending Uppsala University Hospital have undergone endoscopic injection with proprietary non-
Autor:
Ammar Nadhom Farman Al-Mashhadi, Tryggve Nevéus, Göran Läckgren, Mattias Carlström, Michael Häggman, A. Erik G. Persson, Arne Stenberg, Sam Ladjevardi
Publikováno v:
Upsala Journal of Medical Sciences
Upsala Journal of Medical Sciences, Vol 123, Iss 4, Pp 216-224 (2018)
Upsala Journal of Medical Sciences, Vol 123, Iss 4, Pp 216-224 (2018)
Background: As much as 20% of all cases of hypertension are associated with kidney malfunctions. We have previously demonstrated in animals and in pediatric patients that hydronephrosis causes hypertension, which was attenuated by surgical relief of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b17fc920dec74551a8cf3714480921c
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-375862
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-375862
Autor:
Nevééus, Gööran Lääckgren, Torsten Tuvemo, Jerker Hetta, Kelm Hjäälmåås, Arne Stenberg, Tryggve
Publikováno v:
Scandinavian Journal of Urology & Nephrology. Aug2000, Vol. 34 Issue 206, p1-44. 44p.
Autor:
Göran Läckgren, Arne Stenberg
Publikováno v:
Journal of Pediatric Urology. 3:80-85
Objective Vesicoureteral reflux (VUR) can be treated with open surgery, antibiotic therapy or endoscopic injection. A goal in children is to reduce the incidence of febrile urinary tract infections (UTIs). The present long-term observational study in
Publikováno v:
Acta Paediatrica. 88:62-71
Endoscopic subureteric injection of tissue-augmenting substances has become an alternative to long-term antibiotic prophylaxis and open surgery in the treatment of children with vesico-ureteric reflux. Successful elimination of reflux in about 80% of
Publikováno v:
Journal of Urology. 170:1551-1555
Endoscopic injection of dextranomer/hyaluronic acid (Dx/HA) copolymer is an increasingly established treatment for primary vesicoureteral reflux (VUR) in children. We performed a retrospective analysis to assess this treatment for VUR associated with
Autor:
Y. Aigrain, Göran Läckgren, Arne Stenberg, M.-J. Rouffet, M.-O. Bau, Marc Margaryan, Alaa El-Ghoneimi, M. Bernuy, H.B. Lottmann
Publikováno v:
Journal of Urology. 168:1863-1867
Purpose: A prospective study was conducted to assess the efficacy of dextranomer based implants as a new bulking agent for endoscopic treatment of pediatric structural incontinence.Materials and Methods: A total of 33 children and adolescents 5 to 18